CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $44,466
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$44,466. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-08 | RODINO III PETER W. Dir Govt Relations/Sectry | Conversion | +63,000 | 171,373 | ||
| 2019-05-08 | STRAYER DAVID R Chief Science/Medical Officer | Conversion | +35,000 | 129,304 | ||
| 2019-05-08 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Conversion | +227,500 | 1,364,207 | ||
| 2019-05-08 | PASCALE ADAM CFO | Conversion | +35,000 | 147,148 | ||
| 2019-05-06 | MITCHELL WILLIAM M Director | Other acquisition | +18,101 | $0.21 | $4K | 56,450 |
| 2019-05-06 | APPELROUTH STEWART Director | Other acquisition | +18,101 | $0.21 | $4K | 314,741 |
| 2019-05-03 | MITCHELL WILLIAM M Director | Other acquisition | +27,152 | $0.14 | $4K | 38,349 |
| 2019-05-03 | APPELROUTH STEWART Director | Other acquisition | +27,152 | $0.14 | $4K | 296,640 |
| 2019-03-25 | APPELROUTH STEWART Director | Conversion | +140,000 | 518,096 | ||
| 2019-03-25 | SPRINGATE WAYNE S Sr. VP of Operations | Conversion | +50,000 | 117,273 | ||
| 2019-03-25 | STRAYER DAVID R Chief Science/Medical Officer | Conversion | +50,000 | 94,304 | ||
| 2019-03-19 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Purchase | +13,400 | $0.18 | $2K | 811,707 |
| 2019-03-18 | MITCHELL WILLIAM M Director | Conversion | +200,000 | 319,805 | ||
| 2019-03-18 | RODINO III PETER W. Dir Govt Relations/Sectry | Conversion | +90,000 | 108,373 | ||
| 2019-03-18 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Conversion | +325,000 | 1,136,707 | ||
| 2019-03-18 | PASCALE ADAM CFO | Conversion | +50,000 | 112,148 | ||
| 2019-03-04 | MITCHELL WILLIAM M Director | Option exercise | +40 | 40 | ||
| 2019-03-04 | MITCHELL WILLIAM M Director | Option exercise | +200,000 | 200,000 | ||
| 2019-03-04 | MITCHELL WILLIAM M Director | Option exercise · Subr Rights(to buy) | +40 | $1,000.00 | $40K | 0 |
| 2019-03-04 | STRAYER DAVID R Chief Science/Medical Officer | Option exercise | +10 | 10 |
Page 11 of 14 · 264 trades